Frequency of Respiratory Adverse Events (AE) Reported During Active Hemovigilance After Transfusion of INTERCEPT™ Platelet Components (PC)

被引：0
|
作者：
Corash, L. [1 ]
机构：
[1] Cerus Corp, Med Affairs, Concord, CA USA
来源：
TRANSFUSION | 2012年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：171A / 171A
页数：1
相关论文
共 2 条
  • [1] Transfusion-associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24?h follow-up. A prospective cohort study
    Bueno, Jose L.
    Bocanegra, Ana B.
    Sanchez, Isabel
    Mateos, Jose M.
    Puyuelo, Alba
    Garcia Erce, Jose A.
    Villanueva, Hector
    Reano, Maria M.
    Nunez, Lucia
    Losa, Azucena
    Arias, Ana
    Aguilar, Miriam
    Richart, Luis A.
    Martinez, Fatima
    Salgado, Rosario
    Royuela, Ana
    Cruz-Bermudez, Juan L.
    Fernandez, Roberto
    Fores, Rafael
    Fornet, Inocencia
    Ojeda, Emilio
    Cabrera, Rafael
    Duarte, Rafael F.
    TRANSFUSION, 2023, 63 (10) : 1859 - 1871
  • [2] THE FREQUENCY OF CENTRAL NERVOUS SYSTEM (CNS) BLEEDING IN PLATELET TRANSFUSION DEPENDENT PATIENTS BEFORE AND AFTER INTRODUCTION OF PATHOGEN INACTIVATED COMPONENTS: A 9 YEAR HEMOVIGILANCE SURVEY
    Osselaer, J-C O.
    DeCoene, B. D.
    Thonet, M-C T.
    Corlier, C.
    Sherman, C.
    Corash, L. M.
    Steiger, K.
    Doyen, C.
    VOX SANGUINIS, 2012, 103 : 35 - 36
1